The Lancet Gastroenterology & Hepatology in conversation with
En podcast av The Lancet Group
88 Avsnitt
-
Tim Vanuytsel on spore-forming probiotics in functional dyspepsia
Publicerades: 2021-09-09 -
Raymond Henderson on the economic burden of colorectal cancer
Publicerades: 2021-08-12 -
Sigurður Ólafsson on eliminating hepatitis C in Iceland
Publicerades: 2021-06-22 -
Caroline Ovadia on intrahepatic cholestasis of pregnancy
Publicerades: 2021-06-03 -
Matthew Akiyama on hepatitis C in prisons
Publicerades: 2021-04-12 -
Monika Sarkar on reproductive health in women with liver disease
Publicerades: 2021-03-11 -
Colorectal cancer risk in patients with Crohn’s disease
Publicerades: 2020-03-12 -
Liver damage in young adults
Publicerades: 2020-01-17 -
Treatments for IBS
Publicerades: 2020-01-14 -
Statins and decompensated cirrhosis
Publicerades: 2019-11-27 -
Global burden of pancreatic cancer and colorectal cancer
Publicerades: 2019-11-04 -
Paediatric inflammatory bowel disease
Publicerades: 2019-09-12 -
Transplanting hepatitis C-infected hearts
Publicerades: 2019-08-28 -
Primary anastomosis as a treatment for diverticulitis
Publicerades: 2019-07-31 -
Faecal microbiota transplantation in IBS
Publicerades: 2019-07-30 -
Treating faecal incontinence in women
Publicerades: 2019-07-17 -
Viral hepatitis in children & adolescents
Publicerades: 2019-05-23 -
Whole-body MRI: the STREAMLINE trials
Publicerades: 2019-05-11 -
A new drug for short bowel syndrome
Publicerades: 2019-04-05 -
Eosinophilic oesophagitis endotype classification
Publicerades: 2019-03-09
Hugh Thomas, Deputy Editor at The Lancet Gastroenterology & Hepatology, in conversation with the journal’s authors, explores their latest research and its impact on people’s health, healthcare, and health policy.A monthly audio companion to the journal, this podcast covers a broad range of topics, from predicting clinical outcomes in NAFLD to immunosuppressant withdrawal in patients with Crohn’s disease, the primary antibiotic resistance of Helicobacter pylori to surgical versus non-surgical management of malignant bowel obstruction, and more.
